If you wish to report an adverse event or product complaint, please call 1-800-LILLYRX (1-800-545-5979)
Baqsimi ® (glucagon) nasal powder
This information is provided in response to your request. Resources may contain information about doses, uses, formulations and populations different from product labeling. See Prescribing Information above, if applicable.
Can Baqsimi™ (glucagon) nasal powder cause hypersensitivity and allergic reactions?
Hypersensitivity and allergic reactions have been reported with glucagon. Baqsimi (glucagon) nasal powder is contraindicated in patients with a prior hypersensitivity reaction to glucagon.
Warnings and Precautions Regarding Hypersensitivity and Allergic Reactions
Baqsimi is contraindicated in patients with known hypersensitivity to glucagon or to any of the excipients in Baqsimi.1
Allergic reactions have been reported with glucagon, these include generalized rash and in some cases anaphylactic shock with breathing difficulties and hypotension.1
Baqsimi is contraindicated in patients with a prior hypersensitivity reaction.1
Enclosed Prescribing Information
1Baqsimi [package insert]. Indianapolis, IN: Eli Lilly and Company; 2020.
Date of Last Review: February 08, 2022